BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
64 | 1207.25 | 1208.00 | 10 |
40 | 1207.20 | 1208.45 | 29 |
76 | 1207.10 | 1208.50 | 100 |
3 | 1207.05 | 1208.55 | 1 |
64 | 1207.00 | 1208.60 | 47 |
60041 | Total | Total | 61970 |
As on 20 Nov, 2023 | 09:44
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
64 | 1207.25 | 1208.00 | 10 |
40 | 1207.20 | 1208.45 | 29 |
76 | 1207.10 | 1208.50 | 100 |
3 | 1207.05 | 1208.55 | 1 |
64 | 1207.00 | 1208.60 | 47 |
60041 | Total | Total | 61970 |
As on --
(OI , PRICE )
As on --
Stock with consistent financial performance, quality management, and strong
Open | 1,196.30 |
Previous Close | 1,196.30 |
Volume | 81,147.00 |
Value (Lacs) | 977.13 |
VWAP | 1,203.88 |
Beta |
High | 1,208.50 |
Low | 1,195.30 |
UC Limit | 1,315.90 |
LC Limit | 1,076.70 |
52 Week High | 1,238.45 |
52 Week Low | 628.00 |
TTM EPS See historical trend | 29.24 (+1,849.85% YoY) |
TTM PE See historical trend | 41.18 (Average PE) |
P/B See historical trend | 4.40 (High P/B) |
Face Value | 2.00 |
Mkt Cap (Rs. Cr.) | 54,821 |
Dividend Yield | 0.33 |
20D Avg Volume | 1,263,581 |
20D Avg Delivery(%) | -- |
Sector PE | 45.96 |
Book Value Per Share | 273.79 |
*Delayed by 20 seconds.
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
Lupin gets approval from US FDA for Ganirelix Acetate injection Nov 17 2023 03:54 PM
Hold Lupin; target of Rs 1274: Sharekhan Nov 15 2023 03:56 PM
Lupin and Amman Pharma sign licensing agreement for Ranibizumab biosimilar Nov 10 2023 01:07 PM
Lupin Consolidated September 2023 Net Sales at Rs 5,038.56 crore, up 21.54% Y-o-Y Nov 09 2023 12:27 PM
Qty 228477 | Price 747 | % Traded 0.05 |
Qty 228477 | Price 747 | % Traded 0.05 |
Qty 228477 | Price 707.45 | % Traded 0.05 |
Qty 228477 | Price 707.45 | % Traded 0.05 |
Qty 213033 | Price 680.75 | % Traded 0.05 |
Qty 213033 | Price 680.75 | % Traded 0.05 |
Qty 334753 | Price 690.65 | % Traded 0.07 |
Qty 334753 | Price 690.65 | % Traded 0.07 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 9423708 | Price 1816.67 | % Traded 2.07 |
Qty 9423708 | Price 1816.67 | % Traded 2.07 |
Qty 8346296 | Price 1820.43 | % Traded 1.83 |
Qty 3266472 | Price 1832.77 | % Traded 0.72 |
Qty 2509319 | Price 509.95 | % Traded 0.55 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Qty 15000 | Price 985 | % Traded 0.00 | Post Tnx Hold. 0.03% |
Qty 2650 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0.01% |
Qty 2650 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0.02% |
Qty 5300 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0.2% |
Qty 5300 | Price 943.58 | % Traded 0.00 | Post Tnx Hold. 0.2% |
Qty 20000 | Price 974 | % Traded 0.00 | Post Tnx Hold. 0% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
Qty 162700 | Price 0 | % Traded 0.03 | Post Tnx Hold. 45.27% |
Qty 1505892 | Price 0 | % Traded 0.33 | Post Tnx Hold. 5.08% |
Qty 9161996 | Price 0 | % Traded 2.01 | Post Tnx Hold. 6.62% |
Qty 379100 | Price 0 | % Traded 0.08 | Post Tnx Hold. 5% |
Qty 148600 | Price 0 | % Traded 0.03 | Post Tnx Hold. 5.03% |
Qty 12200 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0.2% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Lupin | 1,196.30 | 0.19 | 54,463.60 | 40.91 | 3.97 | 3.45 | 62.52 | 447 | 16,641 | 0.34 |
Sun Pharma | 1,194.60 | 0.42 | 286,624.56 | 33.53 | 5.61 | 15.13 | 17.89 | 8,560 | 43,885 | 0.11 |
Cipla | 1,249.40 | 1.18 | 100,867.24 | 29.25 | 4.77 | 11.96 | 11.60 | 2,835 | 22,753 | 0.02 |
Divis Labs | 3,600.85 | 1.48 | 95,591.25 | 71.77 | 8.15 | 14.28 | 9.45 | 1,823 | 7,767 | 0.00 |
Dr Reddys Labs | 5,611.55 | 1.21 | 93,598.89 | 18.38 | 4.86 | 19.35 | 26.92 | 4,470 | 24,669 | 0.05 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>